MY ABPI LOGIN
 
Tags - News

Northern Ireland life sciences sector ‘flourishing’

The growing importance of Northern Ireland’s pharmaceutical and life sciences industries is revealed in a new report tracking the significant contribution the sector makes to the NI economy.

ABPI response to PM's Brexit comments

The Prime Minister has said that the UK must prepare for 'no deal' but has indicated that negotiations between the EU and UK on the post-Brexit relationship will continue.

ABPI response to UK joining Project Orbis and Access Consortium

The UK is set to join two initiatives bringing together some of the world’s leading regulators to allow pharmaceutical companies to submit medicines to be reviewed by several countries at the same time.

ABPI response to Government-secured Brexit freight capacity

The Department for Transport has announced details of Government-secured freight routes for the end of the Brexit transition period.

New partnership to reduce disease burden in Northern Ireland - starting with Hepatitis C

The ABPI and Northern Ireland’s Medicines Optimisation Innovation Centre have announced a new partnership to deliver ‘triple win’ benefits to patients, NI HSC and the economy.

UK leading Europe in clinical trials, but strategy needed to restart non-COVID research

The UK has been leading the rest of Europe in early-stage clinical research according to new data published by the ABPI in its second annual report on the state of clinical trials in the UK.

Last-ditch attempt to secure ‘bare minimum’ deal on medicines, MPs told

The Chief Executive of the UK’s pharmaceutical industry association has today warned MPs about the consequences of not agreeing a comprehensive post-Brexit trade deal or an urgent agreement on medicines while the trade talks continue.

ABPI response to NHS Confederation reports: NHS Reset and Health inequalities

The NHS Confederation has today published two reports - NHS Reset: A new direction for health and care and Health Inequalities: Time to act.  

COVID threat must inject urgency into trade talks, say UK & EU pharma bodies

The UK and EU pharmaceutical industry are today jointly asking the UK Government and the European Commission to prioritise medicines in trade talks. 

ABPI response to UK genomics strategy

The Department of Health and Social Care has published its National Genomic Healthcare Strategy, which sets out their aim to cement the UK as a global leader in genomics.

'Avoid a 'no deal' Brexit' says UK pharma

“Pharmaceutical companies have done everything in their power to prepare for a ‘no deal’ Brexit. This includes increasing stocks of medicines, changing and adding new supply routes and duplicating manufacturing processes here and in Europe." 
;